APA

Carrato A., Benavides M., Massutí B., Ferreiro-Monteagudo R., García Alfonso P., Falcó E., Reboredo M., Cano T., Gallego J., Viéitez J. M., Layos L., Salud A., Polo E., Dotor E., Durán-Ogalla G., Rodriguez-Garrote M., Calvo A., Grande E. & Aranda E. (20191211). First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). : BMC cancer.

Chicago

Carrato A, Benavides M, Massutí B, Ferreiro-Monteagudo R, García Alfonso P, Falcó E, Reboredo M, Cano T, Gallego J, Viéitez J M, Layos L, Salud A, Polo E, Dotor E, Durán-Ogalla G, Rodriguez-Garrote M, Calvo A, Grande E and Aranda E. 20191211. First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). : BMC cancer.

Harvard

Carrato A., Benavides M., Massutí B., Ferreiro-Monteagudo R., García Alfonso P., Falcó E., Reboredo M., Cano T., Gallego J., Viéitez J. M., Layos L., Salud A., Polo E., Dotor E., Durán-Ogalla G., Rodriguez-Garrote M., Calvo A., Grande E. and Aranda E. (20191211). First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). : BMC cancer.

MLA

Carrato A, Benavides M, Massutí B, Ferreiro-Monteagudo R, García Alfonso P, Falcó E, Reboredo M, Cano T, Gallego J, Viéitez J M, Layos L, Salud A, Polo E, Dotor E, Durán-Ogalla G, Rodriguez-Garrote M, Calvo A, Grande E and Aranda E. First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). : BMC cancer. 20191211.